Apollo Hospitals

Which are the latest news on Apollo Hospitals?

Why is Apollo Hospitals Enterprise Ltd. falling/rising?

As of 05-Sep, Apollo Hospitals Enterprise Ltd. is experiencing a stock price decline to 8,670.00, down 1.3%. This drop is due to underperformance compared to the Sensex and decreased investor participation, despite strong long-term growth indicators.

As of 05-Sep, Apollo Hospitals Enterprise Ltd. is experiencing a decline in its stock price, currently at 8,670.00, which reflects a change of -114.0 or -1.3%. This downward movement can be attributed to several factors. <BR><BR>Firstly, the stock has shown a negative performance over the past week, with a decline of 1.99%, which is worse than the benchmark Sensex's decrease of 0.97%. Additionally, the stock has also fallen by 2.82% over the past month, while the Sensex has decreased by 2.44%. This trend indicates that the stock is underperforming relative to the broader market.<BR><BR>Moreover, there has been a notable decrease in investor participation, as evidenced by a delivery volume of 1.55 lacs on 03 September, which has fallen by 8.62% compared to the 5-day average. This decline in trading activity can contribute to downward pressure on the stock price.<BR><BR>Despite these negative indicators, it is important to note that Apollo Hospitals has demonstrated strong long-term growth, with a year-to-date return of 23.11% and a 9.72% increase over the past year. However, the current market sentiment appears to be overshadowing these positive aspects, leading to the stock's recent decline.

Should I buy, sell or hold Apollo Hospitals Enterprise Ltd.?

Who are in the management team of Apollo Hospitals?

The management team of Apollo Hospitals includes Prathap C Reddy (Executive Chairman), Preetha Reddy (Executive Vice Chairperson), Suneeta Reddy (Managing Director), and Sangita Reddy (Joint Managing Director), along with several independent directors who contribute to the company's governance and strategic direction.

The management team of Apollo Hospitals includes the following key members:<BR><BR>1. **Prathap C Reddy** - Executive Chairman<BR>2. **Preetha Reddy** - Executive Vice Chairperson<BR>3. **Suneeta Reddy** - Managing Director<BR>4. **Sangita Reddy** - Joint Managing Director<BR>5. **Shobana Kamineni** - Executive Vice Chairperson<BR>6. **S M Krishnan** - Senior Vice President & Company Secretary<BR><BR>Additionally, the board includes several independent directors:<BR><BR>1. **Vinayak Chatterjee** - Independent Director<BR>2. **Murali Doraiswamy** - Independent Director<BR>3. **V Kavitha Dutt** - Independent Director<BR>4. **M B N Rao** - Lead Independent Director<BR>5. **Som Mittal** - Independent Director<BR>6. **Rama Bijapurkar** - Independent Director<BR><BR>This team plays a crucial role in the strategic direction and governance of Apollo Hospitals.

What does Apollo Hospitals do?

Apollo Hospitals Enterprise Ltd. is a leading private healthcare provider in Asia, with recent net sales of ₹7,044 Cr and a net profit of ₹581 Cr as of June 2026. The company has a market cap of ₹127,278 Cr and key financial metrics include a P/E ratio of 61.00 and a return on equity of 20.63%.

Overview: <BR>Apollo Hospitals Enterprise Ltd. is a leading private sector healthcare provider in Asia, operating within the hospital industry and classified as a large-cap company.<BR><BR>History: <BR>Apollo Hospitals Enterprise Ltd. was incorporated in the past (exact year not specified) and has maintained its status as a prominent healthcare provider. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 7,044 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 581 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 127,278 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 61.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.23% <BR>Debt-Equity: 0.67 <BR>Return on Equity: 20.63% <BR>Price to Book: 13.42<BR><BR>Contact Details: <BR>Address: No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028 <BR>Tel: 91-44-28290956/28293896 <BR>Email: apolloshares@vsnl.net <BR>Website: http://www.apollohospitals.com

Who are the peers of the Apollo Hospitals?

Apollo Hospitals' peers include Max Healthcare, Fortis Health, Aster DM Quality, Global Health, Narayana Hrudaya, Krishna Institute, Dr. Agarwal's Health, and Rainbow Child. In terms of management risk, growth, and capital structure, Apollo Hospitals ranks average, with Aster DM Quality showing the highest 1-year return at 25.77%, while Apollo Hospitals has a return of 16.48%.

Peers: The peers of Apollo Hospitals are Max Healthcare, Fortis Health., Aster DM Quality, Global Health, Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and Rainbow Child.<BR><BR>Quality Snapshot: Excellent management risk is observed at Apollo Hospitals, Global Health, Narayana Hrudaya, and Rainbow Child, while Average management risk is found at Max Healthcare, Fortis Health., and Dr Agarwal's Hea. Good management risk is noted at Aster DM Quality, Krishna Institu., and the rest. For growth, Apollo Hospitals, Max Healthcare, Narayana Hrudaya, and Dr Agarwal's Hea show excellent or good growth, while Aster DM Quality and Krishna Institu. exhibit below average growth, and the rest. In terms of capital structure, excellent capital structure is seen at Max Healthcare and Global Health, while average capital structure is found at Apollo Hospitals and Aster DM Quality, and good capital structure is noted at Fortis Health., Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, and Rainbow Child.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 25.77%, while the lowest is Max Healthcare at -11.72%. Apollo Hospitals has a 1-year return of 16.48%, which is significantly higher than Max Healthcare but lower than Aster DM Quality. Additionally, Max Healthcare, Fortis Health., and Rainbow Child have negative six-month returns.

How big is Apollo Hospitals?

As of 31st August, Apollo Hospitals Enterprise Ltd. has a market capitalization of 127,278.00 Cr, with recent net sales of 26,429.90 Cr and a net profit of 2,089.50 Cr.

As of 31st August, Apollo Hospitals Enterprise Ltd. has a market capitalization of 127,278.00 Cr, categorizing it as a Large Cap company.<BR><BR>In the latest four quarters, Apollo Hospitals reported Net Sales of 26,429.90 Cr and a Net Profit of 2,089.50 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, with Shareholder's Funds amounting to 9,480.10 Cr and Total Assets valued at 22,182.80 Cr.

Are Apollo Hospitals Enterprise Ltd. latest results good or bad?

Apollo Hospitals Enterprise Ltd. reported strong results for the March 2026 quarter, with net sales of ₹6,605.50 crores and a net profit of ₹529.30 crores, reflecting significant year-on-year growth and improved operational efficiency. Overall, the results are considered good, showcasing the company's solid performance in the healthcare sector.

Apollo Hospitals Enterprise Ltd. has reported strong results for the March 2026 quarter, indicating good performance. The company achieved net sales of ₹6,605.50 crores, reflecting a sequential growth of 1.98% and an impressive year-on-year increase of 18.12%. This marks an all-time high for net sales, showcasing Apollo's ability to expand its operations effectively.<BR><BR>The net profit for the quarter stood at ₹529.30 crores, which is a 5.38% increase compared to the previous quarter and a significant 35.86% increase year-on-year. Additionally, the operating margin improved to 15.31%, the highest in recent quarters, indicating enhanced operational efficiency.<BR><BR>Overall, Apollo Hospitals' financial performance demonstrates consistent growth, strong profitability metrics, and effective cost management, positioning the company favorably within the healthcare sector. The results can be considered good, reflecting the company's solid execution capabilities and favorable industry dynamics.

When is the next results date for Apollo Hospitals Enterprise Ltd.?

The next results date for Apollo Hospitals Enterprise Ltd. is 20 May 2026.

The next results date for Apollo Hospitals Enterprise Ltd. is scheduled for 20 May 2026.

Has Apollo Hospitals Enterprise Ltd. declared dividend?

Yes, Apollo Hospitals Enterprise Ltd. has declared a dividend of 200%, amounting to ₹10 per share, with an ex-date of February 16, 2026. The dividend yield is 0.25%, contributing to positive total returns across various periods.

Apollo Hospitals Enterprise Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 200%<BR>- Amount per share: 10<BR>- Ex-date: 16 Feb 26<BR><BR>Dividend Yield: 0.25%.<BR><BR>Total Returns by Period:<BR>In the 3 Months period, the price return was 0.52%, the dividend return was 0.13%, resulting in a total return of 0.65%.<BR><BR>In the 6 Months period, the price return was 4.21%, the dividend return was 0.25%, leading to a total return of 4.46%.<BR><BR>In the 1 Year period, the price return was 17.92%, the dividend return was 0.32%, culminating in a total return of 18.24%.<BR><BR>In the 2 Years period, the price return was 13.99%, the dividend return was 0.58%, resulting in a total return of 14.57%.<BR><BR>In the 3 Years period, the price return was 70.71%, the dividend return was 1.23%, leading to a total return of 71.94%.<BR><BR>In the 4 Years period, the price return was 66.7%, the dividend return was 1.54%, culminating in a total return of 68.24%.<BR><BR>In the 5 Years period, the price return was 174.48%, the dividend return was 2.57%, resulting in a total return of 177.05%.<BR><BR>Overall, Apollo Hospitals Enterprise Ltd. has declared a significant dividend, which contributes to its total returns across various periods, indicating a strong performance in both price appreciation and dividend distribution.

Is Apollo Hospitals technically bullish or bearish?

As of December 3, 2025, Apollo Hospitals shows a mildly bearish trend, driven by bearish signals from the MACD, KST, and OBV on weekly and monthly charts, despite some mixed indicators from Bollinger Bands and daily moving averages.

As of 3 December 2025, the technical trend for Apollo Hospitals has changed from sideways to mildly bearish. The current technical stance is mildly bearish. Key indicators driving this stance include the MACD on both weekly and monthly time frames showing mildly bearish signals, along with the KST and OBV also indicating mild bearishness on the weekly and monthly charts. The Bollinger Bands present a mixed view, being bearish on the weekly but mildly bullish on the monthly. The daily moving averages suggest a mildly bullish position, but this is overshadowed by the overall bearish indicators in the longer time frames.

How has been the historical performance of Apollo Hospitals?

Apollo Hospitals has shown consistent growth in net sales and profitability, with net sales increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25, and profit after tax rising from 199.18 Cr to 1,472.10 Cr in the same period. The company has also improved its earnings per share from 16.97 to 100.55 and demonstrated strong asset growth.

Answer:<BR>The historical performance of Apollo Hospitals shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Apollo Hospitals has demonstrated significant growth in net sales, increasing from 9,617.44 Cr in Mar'19 to 21,794.00 Cr in Mar'25. The total operating income followed a similar trend, reaching 21,794.00 Cr in Mar'25, up from 16,612.50 Cr in Mar'23. The operating profit (PBDIT) also rose notably, from 1,095.10 Cr in Mar'19 to 3,222.10 Cr in Mar'25, reflecting an operating profit margin of 13.87% in the latest year. Profit before tax surged to 2,006.10 Cr in Mar'25, with profit after tax reaching 1,472.10 Cr, marking a significant increase from 199.18 Cr in Mar'19. The earnings per share (EPS) improved dramatically from 16.97 in Mar'19 to 100.55 in Mar'25. On the balance sheet, total assets grew from 11,288.80 Cr in Mar'20 to 20,644.30 Cr in Mar'25, while total liabilities increased from 11,288.80 Cr to 20,644.30 Cr in the same period. Cash flow from operating activities has also shown positive growth, reaching 2,136.00 Cr in Mar'25, contributing to a closing cash balance of 578.00 Cr. Overall, Apollo Hospitals has exhibited robust financial performance with increasing revenues, profits, and asset growth over the years.

Is Apollo Hospitals overvalued or undervalued?

As of October 30, 2025, Apollo Hospitals is considered undervalued with an attractive valuation grade, featuring a PE ratio of 71.16, a lower PEG ratio of 1.37 compared to peers, and an 11.30% return over the past year, outperforming the Sensex's 5.58%.

As of 30 October 2025, Apollo Hospitals has moved from a fair to an attractive valuation grade, indicating a shift in its perceived value. The company is currently considered undervalued, particularly when compared to its peers. Key ratios include a PE ratio of 71.16, an EV to EBITDA of 36.59, and a ROE of 17.61%. <BR><BR>In comparison to its peers, Apollo Hospitals stands out with a lower PEG ratio of 1.37, while competitors such as Max Healthcare and Fortis Health are deemed very expensive with PE ratios of 94.85 and 85.21, respectively. Additionally, despite a slight decline in the past week, Apollo Hospitals has outperformed the Sensex over the past year with a return of 11.30% compared to the Sensex's 5.58%, reinforcing its attractive valuation in the current market.

Who are the top shareholders of the Apollo Hospitals?

The top shareholders of Apollo Hospitals include M/s. Pcr Investments Ltd with 18.93%, Foreign Institutional Investors holding 43.49%, and mutual funds with 15.94%. The highest public shareholder is Mirae Asset Midcap Fund at 2.21%, while individual investors own 3.98%.

The top shareholders of Apollo Hospitals include a mix of institutional and individual investors. The largest shareholder is M/s. Pcr Investments Ltd, which holds 18.93% of the company. Foreign Institutional Investors (FIIs) are significant stakeholders, collectively holding 43.49%. Additionally, mutual funds are represented by 324 schemes, accounting for 15.94% of the shares. The highest public shareholder is Mirae Asset Midcap Fund, with a holding of 2.21%. Individual investors collectively own 3.98% of the company.